|
1
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 15
Suppl 2:ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Buckner JC: Factors influencing survival
in high-grade gliomas. Seminars in oncology Elsevier. 10–14. 2003.
View Article : Google Scholar
|
|
4
|
Curran WJ Jr, Scott CB, Horton J, Nelson
JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO,
Krisch RE, et al: Recursive partitioning analysis of prognostic
factors in three Radiation Therapy Oncology Group malignant glioma
trials. J Natl Cancer Inst. 85:704–710. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeAngelis LM: Brain tumors. N Engl J Med.
344:114–123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fine HA: The basis for current treatment
recommendations for malignant gliomas. J Neurooncol. 20:111–120.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen WT and Kelly T: Seprase complexes in
cellular invasiveness. Cancer Metastasis Rev. 22:259–269. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosenblum JS and Kozarich JW: Prolyl
peptidases: A serine protease subfamily with high potential for
drug discovery. Curr Opin Chem Biol. 7:496–504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jia J, Martin TA, Ye L and Jiang WG: FAP-α
(Fibroblast activation protein-α) is involved in the control of
human breast cancer cell line growth and motility via the FAK
pathway. BMC Cell Biol. 15:162014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mentlein R, Hattermann K, Hemion C,
Jungbluth AA and Held-Feindt J: Expression and role of the cell
surface protease seprase/fibroblast activation protein-α (FAP-α) in
astroglial tumors. Biol Chem. 392:199–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshikawa K, Noguchi K, Nakano Y, Yamamura
M, Takaoka K, Hashimoto-Tamaoki T and Kishimoto H: The Hippo
pathway transcriptional co-activator, YAP, confers resistance to
cisplatin in human oral squamous cell carcinoma. Int J Oncol.
46:2364–2370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee RC, Feinbaum RL and Ambros V: The C.
Elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goscinski MA, Suo Z, Flørenes VA,
Vlatkovic L, Nesland JM and Giercksky KE: FAP-alpha and uPA show
different expression patterns in premalignant and malignant
esophageal lesions. Ultrastruct Pathol. 32:89–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang C, Shen F, Du J, Hu Z, Li X, Su J,
Wang X and Huang X: MicroRNA-564 is downregulated in glioblastoma
and inhibited proliferation and invasion of glioblastoma cells by
targeting TGF-β1. Oncotarget. 7:56200–56208. 2016.PubMed/NCBI
|
|
17
|
Gao YT, Chen XB and Liu HL: Up-regulation
of miR-370-3p restores glioblastoma multiforme sensitivity to
temozolomide by influencing MGMT expression. Sci Rep. 6:329722016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song S, Fajol A, Tu X, Ren B and Shi S:
miR-204 suppresses the development and progression of human
glioblastoma by targeting ATF2. Oncotarget. 7:70058–70065. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mao J, Zhang M, Zhong M, Zhang Y and Lv K:
MicroRNA-204, a direct negative regulator of ezrin gene expression,
inhibits glioma cell migration and invasion. Mol Cell Biochem.
396:117–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia Z, Liu F, Zhang J and Liu L: Decreased
expression of MiRNA-204-5p contributes to glioma progression and
promotes glioma cell growth, migration and invasion. PLoS One.
10:e01323992015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu DL, Sookthai D, Le Cornet C, Katzke VA,
Johnson TS, Kaaks R and Fortner RT: Reproducibility of serum
oxysterols and lanosterol among postmenopausal women: Results from
EPIC-Heidelberg. Clin Biochem. 52:117–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sato A, Sunayama J, Matsuda K, Seino S,
Suzuki K, Watanabe E, Tachibana K, Tomiyama A, Kayama T and
Kitanaka C: MEK-ERK Signaling Dictates DNA-Repair Gene MGMT
expression and temozolomide resistance of stem-like glioblastoma
cells via the MDM2-p53 Axis. Stem Cells. 29:1942–1951. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li P, Lu X, Wang Y, Sun L, Qian C, Yan W,
Liu N, You Y and Fu Z: MiR-181b suppresses proliferation of and
reduces chemoresistance to temozolomide in U87 glioma stem cells. J
Biomed Res. 24:436–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G,
Luo Z, Li G and Wu M: miR-181 subunits enhance the chemosensitivity
of temozolomide by Rap1B-mediated cytoskeleton remodeling in
glioblastoma cells. Med Oncol. 31:8922014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Anido J, Sáez-Borderías A, Gonzàlez-Juncà
A, Rodón L, Folch G, Carmona MA, Prieto-Sánchez RM, Barba I,
Martínez-Sáez E, Prudkin L, et al: TGF-β receptor inhibitors target
the CD44(high)/Id1(high) glioma-initiating cell population in human
glioblastoma. Cancer Cell. 18:655–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stupp R, Mason WP, Van Den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hegi ME, Diserens AC, Gorlia T, Hamou MF,
de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani
L, et al: MGMT gene silencing and benefit from temozolomide in
glioblastoma. N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li
CH and Leung GK: MicroRNA-21 inhibition enhances in vitro
chemosensitivity of temozolomide-resistant glioblastoma cells.
Anticancer Res. 32:2835–2841. 2012.PubMed/NCBI
|
|
30
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
